HCA Holdings Inc is a leading healthcare company that operates a vast network of hospitals and outpatient facilities across the United States and the United Kingdom. The organization focuses on delivering high-quality medical services, particularly in emergency care, surgical procedures, and specialized treatments. By integrating advanced technology and a skilled workforce, HCA aims to enhance patient experiences and outcomes while maintaining operational efficiency. Additionally, the company emphasizes community engagement and philanthropic efforts to improve healthcare access and foster wellness initiatives in the regions it serves. Read More
Hospital operator HCA Healthcare (NYSE:HCA) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 9.6% year on year to $19.16 billion. The company’s full-year revenue guidance of $75.75 billion at the midpoint came in 0.9% above analysts’ estimates. Its GAAP profit of $6.96 per share was 22.2% above analysts’ consensus estimates.
Wall Street surged to fresh all-time highs Friday as a softer-than-expected inflation reading strengthened market conviction that the Federal Reserve will cut interest rates by 25 basis points at its Oct. 30 policy meeting.
HCA Healthcare beats Q3 estimates with 9.6% revenue growth and higher earnings, raising its 2025 guidance on strong patient volume and stable conditions.
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.
HCA Healthcare beats Q3 2025 earnings estimates, reporting strong revenue and EPS. The company also raised its full-year guidance, boosting investor confidence.
Hospital operator HCA Healthcare (NYSE:HCA) announced better-than-expected revenue in Q3 CY2025, with sales up 9.6% year on year to $19.16 billion. The company’s full-year revenue guidance of $75.75 billion at the midpoint came in 0.9% above analysts’ estimates. Its GAAP profit of $6.96 per share was 22.2% above analysts’ consensus estimates.
HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced it will host its seventh annual “Crush the Crisis” national prescription drug take back day on Saturday, Oct. 25, 2025. This year, HCA Healthcare facilities across the country will partner with local law enforcement to help communities safely and anonymously dispose of unused or expired medications at more than 140 collection sites.
Colorado's economic landscape in the third quarter of 2025 presented a nuanced picture, showcasing both resilience and emerging caution. While the state continued to exhibit steady job growth and a rising Gross Domestic Product (GDP), a notable dip in new business filings from the previous quarter signaled a potential cooling
In a landmark development set to redefine diagnostic reporting and regulatory adherence in the medical field, Smart Reporting announced yesterday, October 16, 2025, its definitive agreement to acquire Fluency for Imaging. This strategic merger will culminate in the formation of a new entity, JacobianTM, poised to become a dominant force in AI-powered radiology reporting and [...]
HCA Healthcare has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 25.2% to $419.60 per share while the index has gained 25.5%.
Cincinnati-based startup Heylo has announced a significant stride in its mission to revolutionize care for individuals with intellectual and developmental disabilities (I/DD) with the appointment of Brian Hart as its inaugural Chief Executive Officer. This strategic move signals a robust push towards scaling tech-driven remote support solutions, promising to
When Wall Street turns bearish on a stock, it’s worth paying attention.
These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
Washington D.C., October 6, 2025 – The American labor market appears to have hit a significant speed bump, with Moody's Analytics reporting "essentially no job growth" for the U.S. in September 2025. This concerning assessment comes at a critical juncture for the economy, compounded by an ongoing federal government
